Investing Now for the Next Generation of Alliance Managers

In the race to bring critical therapies to market, small to medium biotech and pharma companies are increasingly relying on strategic partnerships. And according to Jay McBain's 2022 ASAP Global Alliance Summit presentation "The Alliances Tipping Point: Opportunity or Risk?" 82 percent of companies are investing more in partnerships in 2022. But putting a partnering strategy into execution involves more than just bullet points on a slide. What if there is no current alliance management function, or only a legacy model that needs to reboot and scale? Which alliance management core capabilities are most important when hiring new talent? And how do you promote a culture of partnerships within the organization while you simultaneously hire, train, and retain the next generation of alliance professionals?

Hear three different perspectives on building the plane while flying it, hiring the right talent, establishing an alliance management training program, and strengthening your company's partnering expertise. Key learnings will include:


Camille Ingelse
Vantage Partners

Camille is a consultant at Vantage Partners where she works with leading companies across industries, with particular emphasis on pharmaceuticals and life sciences.

Camille's work with individual pharmaceutical clients has focused on helping to drive internal collaboration and operation efficiency. Representative projects include helping to enhance internal collaboration processes for a large biotech; identifying opportunities to enhance combination product manufacturing efficiency for a biopharma; and building a playbook to help an international pharmaceutical company more consistently and efficiently manage a set of key external relationships.

Camille also has extensive experience helping pharmaceutical companies enhance their alliance management capabilities and individual biopharma alliances. She has worked with multiple biopharma companies to enhance alliance management processes and tools and has supported development and delivery of collaboration training for alliance managers. She has also supported joint alliance health checks between partners, including diagnosing opportunities for improvement, aligning partners around a set of priorities, and implementing enhancement recommendations.

Camille is a graduate of Northeastern University, where she studied economics and international affairs.


Matthew Schroeder, CA-AM
Associate Director, Alliances

Matt heads the pharma alliance management team at Illumina, with a portfolio spanning companion diagnostic (CDx) development and commercialization, exploratory research and data insights partnerships, as well as strategic contract research organization (CRO) partnerships.

He has been with Illumina for four years and was a founding member of the Illumina alliance management team. Prior to his current role, Matt worked at a variety of pharma, diagnostic, and medical laboratory companies. Matt began his career in laboratory medicine as a clinical laboratory scientist and has also held roles in laboratory operations management and program management prior to discovering the alliance management profession.

Matt is passionate about training and educating the next generation of alliance professionals, as well as the intersection of genomics and oncology drug development. Matt joined the Association of Strategic Alliance Professionals in 2018, obtained the Certification of Achievement in Alliance Management (CA-AM), and is excited to contribute thought leadership to the ASAP community.

Carl Waiters
Head of Alliance Management

Carl is an experienced alliance management professional with 18 years of pharmaceutical and biotech experience across the entire value chain with a focus on strategic alliance leadership and business development. Carl has deep knowledge in managing human risk, business risk, and legal uncertainties associated with global strategic partnerships across research, development, and commercialization. He is currently the head of alliance and project management at ImmunoGen, Inc. and has worked at other biotech and pharma companies, namely Eli Lilly for a 14-year period.

Stefan Walke, PhD
Head of Alliance Management
Boehringer Ingelheim

Trained in Biochemistry, Stefan gained 20 years of health care related experience in consulting, biotech and pharma–always with a strong focus on strategy and business development. Within the human pharma business development organization at Boehringer Ingelheim, he was leading the contracts & alliance management team globally, before taking up the newly established role as global head of alliance management to further strengthen Boehringer's relationship with a strongly growing portfolio of strategic external innovation partners across the globe.